BridgeBio Pharma Inc (BBIO)
24.10
-0.69
(-2.78%)
USD |
NASDAQ |
Nov 14, 16:00
24.10
0.00 (0.00%)
After-Hours: 20:00
BridgeBio Pharma Gross Profit (Annual): 6.857M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.857M |
| December 31, 2022 | 74.21M |
| December 31, 2021 | 66.60M |
| December 31, 2020 | 8.249M |
| Date | Value |
|---|---|
| December 31, 2019 | 38.06M |
| December 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
6.857M
Minimum
2023
74.21M
Maximum
2022
38.80M
Average
38.06M
Median
2019
Gross Profit (Annual) Benchmarks
| Alnylam Pharmaceuticals Inc | 1.518B |
| Pfizer Inc | 33.54B |
| Vertex Pharmaceuticals Inc | 8.607B |
| PTC Therapeutics Inc | 872.34M |
| Bristol-Myers Squibb Co | 34.31B |